X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (223) 223
female (162) 162
male (158) 158
middle aged (155) 155
adult (149) 149
index medicus (149) 149
hematology (145) 145
aged (111) 111
treatment outcome (87) 87
prognosis (85) 85
adolescent (79) 79
oncology (76) 76
cancer (63) 63
life sciences (58) 58
chemotherapy (57) 57
young adult (53) 53
antineoplastic combined chemotherapy protocols - therapeutic use (49) 49
leukemia, myeloid, acute - drug therapy (48) 48
disease-free survival (47) 47
abridged index medicus (46) 46
leukemia, myeloid, acute - genetics (46) 46
survival rate (44) 44
acute myeloid leukemia (41) 41
aged, 80 and over (40) 40
therapy (39) 39
acute myeloid-leukemia (38) 38
remission induction (38) 38
recurrence (36) 36
survival analysis (36) 36
leukemia (35) 35
mutation (35) 35
retrospective studies (33) 33
acute myelogenous leukemia (32) 32
antineoplastic agents - therapeutic use (32) 32
leukemia, myeloid, acute - mortality (30) 30
aml (28) 28
minimal residual disease (28) 28
immunology (27) 27
hemic and lymphatic diseases (26) 26
leukemia, myeloid, acute - diagnosis (26) 26
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (25) 25
child (24) 24
risk factors (24) 24
time factors (24) 24
follow-up studies (23) 23
survival (22) 22
leukemia, myeloid, acute - therapy (21) 21
relapse (21) 21
trial (21) 21
[sdv.can]life sciences [q-bio]/cancer (20) 20
acute lymphoblastic-leukemia (20) 20
cytarabine - administration & dosage (20) 20
[ sdv.can ] life sciences [q-bio]/cancer (19) 19
adults (19) 19
drug administration schedule (19) 19
mutations (19) 19
stem-cell transplantation (19) 19
hematology, oncology and palliative medicine (18) 18
trans-retinoic acid (18) 18
acute lymphoblastic leukemia (17) 17
antineoplastic agents - adverse effects (17) 17
care and treatment (17) 17
france (17) 17
leukemia, promyelocytic, acute - drug therapy (17) 17
stem cell transplantation (17) 17
acute disease (16) 16
antineoplastic agents - administration & dosage (16) 16
child, preschool (16) 16
children (16) 16
expression (16) 16
intensive chemotherapy (16) 16
philadelphia chromosome (16) 16
prospective studies (16) 16
acute promyelocytic leukemia (15) 15
daunorubicin - administration & dosage (15) 15
elderly-patients (15) 15
induction chemotherapy (15) 15
neoplasm, residual (15) 15
older patients (15) 15
precursor t-cell lymphoblastic leukemia-lymphoma - genetics (15) 15
translocation, genetic (15) 15
clinical trials (14) 14
cytogenetics (14) 14
diagnosis (14) 14
hematopoietic stem cell transplantation (14) 14
patients (14) 14
remission (14) 14
acute lymphocytic-leukemia (13) 13
antineoplastic combined chemotherapy protocols (13) 13
antineoplastic combined chemotherapy protocols - administration & dosage (13) 13
clinical trials as topic (13) 13
colony-stimulating factor (13) 13
imatinib mesylate (13) 13
leukemia, myeloid, acute - pathology (13) 13
transplantation (13) 13
adult patients (12) 12
analysis (12) 12
antimetabolites, antineoplastic - therapeutic use (12) 12
antineoplastic combined chemotherapy protocols - adverse effects (12) 12
arsenic trioxide (12) 12
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10036, pp. 2402 - 2411
Summary Background Short intensive chemotherapy is the standard of care for adult patients with Burkitt's leukaemia or lymphoma. Findings from single-arm... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | CODOX-M/IVAC | CLEAVED-CELL LYMPHOMA | ACUTE-LYMPHOBLASTIC-LEUKEMIA | MULTIAGENT CHEMOTHERAPY | ADOLESCENTS | PLUS RITUXIMAB | NON-HODGKIN-LYMPHOMA | SURVIVAL RATE | PEDIATRIC-ONCOLOGY-SOCIETY | CHILDREN | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Injections, Intravenous | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Patient Selection | Burkitt Lymphoma - pathology | Hydrocortisone - administration & dosage | Vincristine - administration & dosage | Adult | Female | France | Odds Ratio | Burkitt Lymphoma - drug therapy | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Drug Administration Schedule | Biomarkers, Tumor - analysis | Proportional Hazards Models | Treatment Outcome | Burkitt Lymphoma - diagnosis | Burkitt Lymphoma - chemistry | Cytarabine - administration & dosage | Rituximab - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Methotrexate - administration & dosage | Aged | Bone Marrow Neoplasms - drug therapy | Neoplasm Staging | Central Nervous System Neoplasms - drug therapy | Methylprednisolone - administration & dosage | Chemotherapy | Leukemia | Lymphomas | Adults | Epidemiology | Biometry | Cancer | Survival analysis | Biomedical research | Dehydrogenases | Medical prognosis | Clinical trials | Life Sciences
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9825, pp. 1508 - 1516
Journal Article
Blood, ISSN 0006-4971, 01/2016, Volume 127, Issue 1, pp. 53 - 61
Journal Article
by Bulsei, Julie and Leroy, Sylvie and Perotin, Jeanne-Marie and Mal, Hervé and Marquette, Charles-Hugo and Dutau, Hervé and Bourdin, Arnaud and Vergnon, Jean-Michel and Pison, Christophe and Kessler, Romain and Jounieaux, Vincent and Salaün, Mathieu and Marceau, Armelle and Dukic, Sylvain and Barbe, Coralie and Bonnaire, Margaux and Deslee, Gaëtan and Durand-Zaleski, Isabelle and Dury, Sandra and Vallerand, Hervé and Lebargy, François and Launois, Claire and Pradelli, Johanna and Benzaquen, Jonathan and Buscot, Matthieu and Sanfiorenzo, Celine and Korzeniewski, Sylvia and Mazzetta, Andrea and Griffonnet, Jennifer and Guillemart, Ariane and Makris, Demosthenes and Dombret, Marie Christine and Servin, Frédérique and Debray, Marie Pierre and Laroumagne, Sophie and Bregeon, Fabienne and Gomez, Carine and Astoul, Philippe and Lesavre, Nathalie and Mallet, Jean Pierre and Gamez, Anne Sophie and Tarodo, Philippe and Brousse, Christophe and Broissin, Clément and Thibout, Yoann and Di Palma, Fabrice and Costes, Frédéric and Briault, Amandine and Arbib, François and Reymond, Emilie and Ferrettti, G and Porzio, Michele and Renaud-Picard, Benjamin and Toublanc, Bénédicte and François, Géraldine and Thiberville, Luc and Cuvelier, Antoine and Lachkar, Samy and Gras, Delphine and Benoit, Philippe and Leclainche, Annick and Jolly, Damien and Fourrier, François and Hachulla, Eric and Roche, Nicolas and Dusser, Daniel and REVOLENS Study Grp and REVOLENS study group and the REVOLENS study group
Respiratory Research, ISSN 1465-9921, 05/2018, Volume 19, Issue 1, pp. 84 - 9
Background: The REVOLENS study compared lung volume reduction coil treatment to usual care in patients with severe emphysema at 1 year, resulting in improved... 
QALY | Coil treatment | Cost-effectiveness | Severe emphysema | TRIAL | RESPIRATORY SYSTEM | Bronchoscopy | Care and treatment | Usage | Emphysema, Pulmonary | Analysis | Research | Medical care, Cost of | Life Sciences
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 1, pp. 57 - 66
Journal Article
Blood, ISSN 0006-4971, 11/2011, Volume 118, Issue 20, pp. 5366 - 5367
In their large study of 1185 patients with acute myeloid leukemia (AML), Shen and colleagues have dissected the overlapping incidences and prognostic... 
HEMATOLOGY | ACUTE MYELOID-LEUKEMIA | DNMT3A MUTATIONS
Journal Article
Hematology, ISSN 1520-4391, 12/2017, Volume 2017, Issue 1, pp. 45 - 53
Abstract Remission induction with chemotherapy has long been the frontline treatment of acute myeloid leukemia (AML). However, intensive therapy is limited in... 
Index Medicus
Journal Article
Hematology. American Society of Hematology. Education Program, ISSN 1520-4391, 12/2017, Volume 2017, Issue 1, pp. 45 - 53
Remission induction with chemotherapy has long been the frontline treatment of acute myeloid leukemia (AML). However, intensive therapy is limited in frail... 
Acute Myeloid Leukemia | How Can We Improve Upon Standard Therapy?
Journal Article
Journal Article
Journal Article